BCPC Stock Overview
Develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for BCPC from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Balchem Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$165.49 |
| 52 Week High | US$186.03 |
| 52 Week Low | US$135.84 |
| Beta | 0.67 |
| 1 Month Change | -9.29% |
| 3 Month Change | -5.79% |
| 1 Year Change | 12.76% |
| 3 Year Change | 0.78% |
| 5 Year Change | 64.73% |
| Change since IPO | 66,041.50% |
Recent News & Updates
Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Dec 06Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Recent updates
Is Balchem (NASDAQ:BCPC) A Risky Investment?
Dec 19If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity
Dec 06Balchem Corporation's (NASDAQ:BCPC) Earnings Haven't Escaped The Attention Of Investors
Nov 22Balchem's Q3 Shows Record Earnings And Valuation Pressure
Oct 28Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return
Oct 21Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Oct 07Is Balchem (NASDAQ:BCPC) Using Too Much Debt?
Sep 09Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today
Aug 27Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon
Aug 13Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184
Jul 31Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing
Jun 29Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable
Jun 15Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)
Jun 10Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching
May 26Balchem: A Tale Of Two Businesses
May 10Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear
Mar 21Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 05Balchem: Potential Turnaround Is In The Price
Feb 21These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well
Feb 18Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled
Jan 03Balchem: Acquisitions And Cost Pressures Draw Attention
Sep 12Balchem to acquire Cardinal Associates or Bergstrom Nutrition
Aug 30Balchem Q2 2022 Earnings Preview
Jul 28Balchem: On The M&A Road Again
Jun 28Balchem: A New Growth Stage Is Just Beginning
Jun 02Shareholder Returns
| BCPC | US Chemicals | US Market | |
|---|---|---|---|
| 7D | -5.8% | -4.3% | -2.4% |
| 1Y | 12.8% | -3.4% | 23.4% |
Return vs Industry: BCPC exceeded the US Chemicals industry which returned -3.4% over the past year.
Return vs Market: BCPC underperformed the US Market which returned 23.3% over the past year.
Price Volatility
| BCPC volatility | |
|---|---|
| BCPC Average Weekly Movement | 3.1% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BCPC has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BCPC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 1,300 | Ted Harris | www.balchem.com |
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Balchem Corporation Fundamentals Summary
| BCPC fundamental statistics | |
|---|---|
| Market cap | US$5.38b |
| Earnings (TTM) | US$121.54m |
| Revenue (TTM) | US$942.38m |
44.3x
P/E Ratio5.7x
P/S RatioIs BCPC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BCPC income statement (TTM) | |
|---|---|
| Revenue | US$942.38m |
| Cost of Revenue | US$617.52m |
| Gross Profit | US$324.86m |
| Other Expenses | US$203.32m |
| Earnings | US$121.54m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.74 |
| Gross Margin | 34.47% |
| Net Profit Margin | 12.90% |
| Debt/Equity Ratio | 19.3% |
How did BCPC perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield21%
Payout RatioDoes BCPC pay a reliable dividends?
See BCPC dividend history and benchmarks| Balchem dividend dates | |
|---|---|
| Ex Dividend Date | Dec 26 2024 |
| Dividend Pay Date | Jan 17 2025 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 26 days |
Does BCPC pay a reliable dividends?
See BCPC dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:51 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Balchem Corporation is covered by 11 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Robert Labick | CJS Securities, Inc. |
| Timothy Ramey | D.A. Davidson & Co. |